Sudarshan Pharma Industries has entered into a Rent Agreement with Daundi Biological to acquire premises for a period of 5 years commencing from December 29, 2024 to set up a new Research & Development formulation centre in the city of Dehradun, Uttarakhand, India. It is expected to commence the operations of the formulation R&D Centre in the month of March 2025.
Sudarshan Pharma Industries is engaged in contract manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals.